Calfornia Residents:Privacy StatementCA Privacy Notice 1/27/2022 RICHMOND, Va.--(BUSINESS WIRE)--Altria Group, Inc. (Altria) (NYSE: MO) today reports its 2021 fourth-quarter and full-year business results and provides its 2022 full-year adjusted diluted earnings per share (EPS) guidance. “Altria delivered outstanding results in 2021 across our businesses, including strong financial performance, progress toward our Vision and advancements in our ESG efforts,” said Billy Gifford, Altria’s Chief Executive Officer. “We returned more than $8.1 billion in cash to shareholders in 2021 through dividends and share repurchases. This total represents the third-largest single-year cash return in Altria’s history and the largest annual return since 2002.” “Our plans for the year ahead include a continuation of our strategy to balance earnings growth and shareholder returns with investments toward our Vision. We expect to deliver 2022 full-year adjusted diluted EPS in a range of $4.79 to $4.93, representing a growth rate of 4% to 7% from an adjusted diluted EPS base of $4.61 in 2021.” Altria Headline Financials1 ($ in millions, except per share data) Q4 2021 Change vs. Q4 2020 Full Year 2021 Change vs. Full Year 2020 Net revenues $6,255 (0.8)% $26,013 (0.5)% Revenues net of excise taxes $5,086 0.6% $21,111 1.3% Reported tax rate 28.8% 4.4 pp 35.3% (0.1) pp Adjusted tax rate 25.5% 0.6 pp 25.1% 0.3 pp Reported diluted EPS2 $0.88 (14.6)% $1.34 (44.2)% Adjusted diluted EPS2 $1.09 10.1% $4.61 5.7% 1 “Adjusted” financial measures presented in this release exclude the impact of special items. See “Basis of Presentation” for more information. 2 “EPS” represents diluted earnings (losses) per share attributable to Altria. As previously announced, a conference call with the investment community and news media will be webcast on January 27, 2022 at 9:00 a.m. Eastern Time. Access to the webcast is available at www.altria.com/webcasts. Cash Returns to Shareholders and Capital Markets Activity Share Repurchase Program Dividends Smoke-free Products Business Platform Oral Tobacco Heated Tobacco E-Vapor Environmental, Social and Governance (ESG) Altria’s Corporate Responsibility Focus Areas are (i) reducing the harm of tobacco products, (ii) preventing underage use, (iii) protecting the environment, (iv) driving responsibility through our value chain, (v) supporting our people and communities and (vi) engaging and leading responsibly. Altria’s corporate responsibility reports can be found on the Corporate Responsibility Reports page at www.altria.com/responsibility. Impact of COVID-19 Pandemic Impact on Tobacco Business Operations Impact on ABI, JUUL and Cronos Investments Philip Morris Capital Corporation Update As of December 31, 2021, Altria’s net finance assets balance was $114 million, down $206 million since the end of 2020 due to rents received and asset sales. As previously announced, Altria expects to fully complete the Philip Morris Capital Corporation (PMCC) wind-down by the end of 2022. 2022 Full-Year Guidance Altria expects its 2022 full-year adjusted diluted EPS to be in a range of $4.79 to $4.93, representing a growth rate of 4% to 7% from an adjusted diluted EPS base of $4.61 in 2021. Altria expects 2022 adjusted diluted EPS growth to be weighted toward the second half of the year. While the 2022 full-year adjusted diluted EPS guidance accounts for a range of scenarios, the external environment remains dynamic. Altria will continue to monitor conditions related to (i) the economy, including the impact of increased inflation, (ii) the impact of current and future COVID-19 variants and mitigation strategies, (iii) ATC dynamics, including tobacco usage occasions, available disposable income, purchasing patterns and adoption of smoke-free products and (iv) regulatory and legislative developments. Altria’s 2022 full-year adjusted diluted EPS guidance range includes planned investments in support of its Vision, such as (i) costs to enhance its digital consumer engagement system, (ii) increased smoke-free product research, development and regulatory preparation expenses and (iii) marketplace activities in support of Altria’s smoke-free products. The guidance range also includes anticipated inflationary increases in Master Settlement Agreement expenses and direct materials expenses and Altria’s current expectation that PM USA will not have access to the IQOS system in 2022. Altria expects its 2022 full-year adjusted effective tax rate will be in a range of 24.5% to 25.5%. Altria also expects 2022 capital expenditures to be between $200 million and $250 million and depreciation and amortization expenses of approximately $210 million. Altria’s full-year adjusted diluted EPS guidance and full-year forecast for its adjusted effective tax rate exclude the impact of certain income and expense items that management believes are not part of underlying operations. These items may include, for example, loss on early extinguishment of debt, restructuring charges, asset impairment charges, acquisition-related and disposition-related costs, COVID-19 special items, equity investment-related special items (including any changes in fair value of the equity investment and any related warrants and preemptive rights), certain tax items, charges associated with tobacco and health and certain other litigation items, and resolutions of certain non-participating manufacturer (NPM) adjustment disputes under the 1998 Master Settlement Agreement (such dispute resolutions are referred to as NPM Adjustment Items). Altria’s management cannot estimate on a forward-looking basis the impact of certain income and expense items, including those items noted in the preceding paragraph, on its reported diluted EPS or its reported effective tax rate because these items, which could be significant, may be unusual or infrequent, are difficult to predict and may be highly variable. As a result, Altria does not provide a corresponding U.S. generally accepted accounting principles (GAAP) measure for, or reconciliation to, its adjusted diluted EPS guidance or its adjusted effective tax rate forecast. ALTRIA GROUP, INC. See “Basis of Presentation” below for an explanation of financial measures and reporting segments discussed in this release. Financial Performance Fourth Quarter Full Year Table 1 - Altria’s Adjusted Results Fourth Quarter Full Year 2021 2020 Change 2021 2020 Change Reported diluted EPS $ 0.88 $ 1.03 (14.6) % $ 1.34 $ 2.40 (44.2) % NPM Adjustment Items — — (0.03) — Asset impairment, exit, implementation, acquisition and disposition-related costs — 0.02 0.05 0.18 Tobacco and health and certain other litigation items 0.02 — 0.07 0.03 Impairment of JUUL equity securities — — — 1.40 JUUL changes in fair value — (0.05) — (0.05) ABI-related special items 0.04 0.03 2.66 0.32 Cronos-related special items 0.15 (0.04) 0.25 0.03 Loss on early extinguishment of debt — — 0.27 — COVID-19 special items — — — 0.02 Tax items — — — 0.03 Adjusted diluted EPS $ 1.09 $ 0.99 10.1 % $ 4.61 $ 4.36 5.7 % Note: For details of pre-tax, tax and after-tax amounts, see Schedules 7 and 9. Special Items The EPS impact of the following special items is shown in Table 1 and Schedules 6, 7, 8 and 9. Non-Participating Manufacturer (NPM) Adjustment Items Implementation, acquisition and disposition-related costs . Tobacco and Health and Certain Other Litigation Items Impairment of JUUL Equity Securities In the fourth quarter of 2020, Altria elected to account for its investment in JUUL under the fair value option. Prior to this date, Altria accounted for its investment in JUUL as an investment in an equity security. JUUL Changes in Fair Value ABI-Related Special Items The ABI-related special items above include Altria’s respective share of the amounts recorded by ABI and additional adjustments related to (i) conversion from international financial reporting standards to GAAP and (ii) adjustments to Altria’s investment required under the equity method of accounting. Cronos-Related Special Items In the fourth quarter and for full-year 2021, Altria recorded net pre-tax (income) expense consisting of the following: Fourth Quarter Full Year ($ in millions, except per share data) 2021 2020 2021 2020 (Gain) loss on Cronos-related financial instruments 1 $ 20 $ (62 ) $ 148 $ 140 (Income) losses from equity investments 2 246 (31 ) 318 (89 ) Total Cronos-related special items - (income) expense $ 266 $ (93 ) $ 466 $ 51 Earnings per share $ 0.15 $ (0.04 ) $ 0.25 $ 0.03 1 Amounts are related to the non-cash change in the fair value of the warrant and certain anti-dilution protections (both acquired in March 2019). 2 Amounts include Altria’s share of special items recorded by Cronos and additional adjustments, if required under the equity method of accounting, related to Altria’s investment in Cronos. The amounts above include a non-cash, pre-tax impairment charge of $205 million for the three and twelve months ended December 31, 2021, reflecting the difference between the fair value of Altria’s investment in Cronos using Cronos’s share price at December 31, 2021 and the carrying value of Altria’s investment in Cronos at December 31, 2021. Loss on Early Extinguishment of Debt COVID-19 Special Items Tax Items SMOKEABLE PRODUCTS Revenues and OCI Fourth Quarter Full Year Table 2 - Smokeable Products: Revenues and OCI ($ in millions) Fourth Quarter Full Year 2021 2020 Change 2021 2020 Change Net revenues $ 5,591 $ 5,567 0.4 % $ 22,866 $ 23,089 (1.0) % Excise taxes (1,134) (1,212) (4,754) (5,162) Revenues net of excise taxes $ 4,457 $ 4,355 2.3 % $ 18,112 $ 17,927 1.0 % Reported OCI $ 2,493 $ 2,376 4.9 % $ 10,394 $ 9,985 4.1% NPM Adjustment Items — 4 (53) 4 Asset impairment, exit, implementation, acquisition and disposition-related costs — 2 — 2 Tobacco and health and certain other litigation items 11 6 83 79 COVID-19 special items — — — 41 Adjusted OCI $ 2,504 $ 2,388 4.9 % $ 10,424 $ 10,111 3.1 % Adjusted OCI margins 1 56.2% 54.8% 1.4 pp 57.6% 56.4% 1.2 pp 1 Adjusted OCI margins are calculated as adjusted OCI divided by revenues net of excise taxes. Shipment Volume Fourth Quarter Full Year Table 3 - Smokeable Products: Reported Shipment Volume (sticks in millions) Fourth Quarter Full Year 2021 2020 Change 2021 2020 Change Cigarettes: Marlboro 19,848 20,968 (5.3) % 82,970 88,858 (6.6) % Other premium 1,036 1,070 (3.2) % 4,216 4,566 (7.7) % Discount 1,539 1,796 (14.3) % 6,607 8,001 (17.4) % Total cigarettes 22,423 23,834 (5.9) % 93,793 101,425 (7.5) % Cigars: Black & Mild 440 473 (7.0) % 1,796 1,790 0.3 % Other 2 2 — % 7 10 (30.0) % Total cigars 442 475 (6.9) % 1,803 1,800 0.2 % Total smokeable products 22,865 24,309 (5.9) % 95,596 103,225 (7.4) % Note: Cigarettes volume includes units sold as well as promotional units, but excludes units sold for distribution to Puerto Rico, and units sold in U.S. Territories, to overseas military and by Philip Morris Duty Free Inc., none of which, individually or in the aggregate, is material to the smokeable products segment. Retail Share and Brand Activity Fourth Quarter Full Year Table 4 - Smokeable Products: Cigarettes Retail Share (percent) Fourth Quarter Full Year 2021 2020 Percentage 2021 2020 Percentage Cigarettes: Marlboro 42.7% 43.1% (0.4) 43.1% 42.9% 0.2 Other premium 2.3 2.3 — 2.3 2.3 — Discount 3.3 3.7 (0.4) 3.4 3.9 (0.5) Total cigarettes 48.3% 49.1% (0.8) 48.8% 49.1% (0.3) Note: Retail share results for cigarettes are based on data from IRI/MSAi, a tracking service that uses a sample of stores and certain wholesale shipments to project market share and depict share trends. This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes. For other trade classes selling cigarettes, retail share is based on shipments from wholesalers to retailers (STARS). This service is not designed to capture sales through other channels, including the internet, direct mail and some illicitly tax-advantaged outlets. It is IRI’s standard practice to periodically refresh its services, which could restate retail share results that were previously released in this service. ORAL TOBACCO PRODUCTS Revenues and OCI Fourth Quarter Full Year Table 5 - Oral Tobacco Products: Revenues and OCI ($ in millions) Fourth Quarter Full Year 2021 2020 Change 2021 2020 Change Net revenues $ 663 $ 632 4.9 % $ 2,608 $ 2,533 3.0% Excise taxes (34) (32) (132) (130) Revenues net of excise taxes $ 629 $ 600 4.8 % $ 2,476 $ 2,403 3.0% Reported OCI $ 390 $ 421 (7.4) % $ 1,659 $ 1,718 (3.4) % Asset impairment, exit, implementation, acquisition and disposition-related costs — (9) 37 (3) COVID-19 special items — — — 9 Adjusted OCI $ 390 $ 412 (5.3) % $ 1,696 $ 1,724 (1.6) % Adjusted OCI margins 1 62.0% 68.7% (6.7) pp 68.5% 71.7% (3.2) pp 1 Adjusted OCI margins are calculated as adjusted OCI divided by revenues net of excise taxes. Shipment Volume Fourth Quarter Full Year Table 6 - Oral Tobacco Products: Reported Shipment Volume (cans and packs in millions) Fourth Quarter Full Year 2021 2020 Change 2021 2020 Change Copenhagen 125.2 127.4 (1.7 ) % 503.6 522.4 (3.6 ) % Skoal 49.2 51.3 (4.1 ) % 197.4 208.5 (5.3 ) % Other (includes Red Seal and on!) 31.6 23.7 33.3 % 119.3 88.7 34.5 % Total oral tobacco products 206.0 202.4 1.8 % 820.3 819.6 0.1 % Note: Volume includes cans and packs sold, as well as promotional units, but excludes international volume, which is currently not material to the oral tobacco products segment. New types of oral tobacco products, as well as new packaging configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis. To calculate volumes of cans and packs shipped, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack, is assumed to be equivalent to one can of MST. Retail Share & Brand Activity Fourth Quarter Full Year Table 7 - Oral Tobacco Products: Retail Share (percent) Fourth Quarter Full Year 2021 2020 Percentage point change 2021 2020 Percentage point change Copenhagen 28.6 % 31.2 % (2.6 ) 29.4 % 31.8 % (2.4 ) Skoal 12.1 13.4 (1.3 ) 12.6 13.9 (1.3 ) Other (includes Red Seal and on!) 6.9 4.6 2.3 5.8 4.2 1.6 Total oral tobacco products 47.6 % 49.2 % (1.6 ) 47.8 % 49.9 % (2.1 ) Note: The oral tobacco products retail share results exclude international volume. Retail share results for oral tobacco products are based on data from IRI InfoScan, a tracking service that uses a sample of stores to project market share and depict share trends. This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes on the number of cans and packs sold. Oral tobacco products is defined by IRI as moist smokeless, snus and oral nicotine pouches. New types of oral tobacco products, as well as new packaging configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis. For example, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack, is assumed to be equivalent to one can of MST. Because this service represents retail share performance only in key trade channels, it should not be considered a precise measurement of actual retail share. It is IRI’s standard practice to periodically refresh its InfoScan services, which could restate retail share results that were previously released in this service. WINE Revenues, OCI and Shipment Volume On October 1, 2021, UST LLC sold its subsidiary, International Wine & Spirits Ltd., which included Ste. Michelle, to Sycamore Partners Management, L.P. Full Year Table 8 - Wine: Revenues and OCI (Loss) ($ in millions) Fourth Quarter Full Year 2021 2020 Change 2021 2020 Change Net revenues $ — $ 180 (100.0) % $ 494 $ 614 (19.5) % Excise taxes — (5 ) (14 ) (19 ) Revenues net of excise taxes $ — $ 175 (100.0) % $ 480 $ 595 (19.3) % Reported OCI (Loss) $ — $ (13 ) 100.0% $ 21 $ (360 ) 100%+ Asset impairment, exit, implementation, acquisition and disposition-related costs — 16 52 411 Adjusted OCI $ — $ 3 (100.0) % $ 73 $ 51 43.1% Adjusted OCI margins 1 — % 1.7 % (1.7) pp 15.2 % 8.6 % 6.6 pp 1 Adjusted OCI margins are calculated as adjusted OCI divided by revenues net of excise taxes. Altria’s Profile Altria has a leading portfolio of tobacco products for U.S. tobacco consumers age 21+. Altria’s Vision by 2030 is to responsibly lead the transition of adult smokers to a smoke-free future (Vision). Altria is Moving Beyond Smoking™, leading the way in moving adult smokers away from cigarettes by taking action to transition millions to potentially less harmful choices - believing it is a substantial opportunity for adult tobacco consumers, Altria’s businesses and society. Altria’s wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, Altria owns Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Altria’s smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, and Helix Innovations LLC (Helix), a rapidly growing manufacturer of oral nicotine pouches. Altria also enhances its smoke-free product portfolio with exclusive U.S. commercialization rights to the IQOS Tobacco Heating System® and Marlboro HeatSticks®, and an equity investment in JUUL Labs, Inc. (JUUL). Altria also owns equity investments in Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company. The brand portfolios of Altria’s tobacco operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal® and on!®. Trademarks and service marks related to Altria referenced in this release are the property of Altria or its subsidiaries or are used with permission. Learn more about Altria at www.altria.com and follow us on Twitter, Facebook and LinkedIn. Basis of Presentation Altria reports its financial results in accordance with GAAP. Altria’s management reviews OCI, which is defined as operating income before general corporate expenses and amortization of intangibles, to evaluate the performance of, and allocate resources to, the segments. Altria’s management also reviews certain financial results, including OCI, OCI margins and diluted EPS, on an adjusted basis, which excludes certain income and expense items, including those items noted under “2022 Full-Year Guidance.” Altria’s management does not view any of these special items to be part of Altria’s underlying results as they may be highly variable, may be unusual or infrequent, are difficult to predict and can distort underlying business trends and results. Altria’s management also reviews income tax rates on an adjusted basis. Altria’s adjusted effective tax rate may exclude certain tax items from its reported effective tax rate. Altria’s management believes that adjusted financial measures provide useful additional insight into underlying business trends and results and provide a more meaningful comparison of year-over-year results. Altria’s management uses adjusted financial measures for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets. These adjusted financial measures are not consistent with GAAP and may not be calculated the same as similarly titled measures used by other companies. These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. Reconciliations of historical adjusted financial measures to corresponding GAAP measures are provided in this release. Altria uses the equity method of accounting for its investment in ABI and Cronos and reports its share of ABI’s and Cronos’s results using a one-quarter lag because ABI’s and Cronos’s results are not available in time to record them in the concurrent period. The one-quarter reporting lag for ABI and Cronos does not affect Altria’s cash flows. In the fourth quarter of 2020, Altria elected to account for its investment in JUUL under the fair value option. Prior to this date, Altria accounted for its investment in JUUL as an investment in an equity security. At December 31, 2021 Altria’s reportable segments are (i) smokeable products, including combustible cigarettes and cigars manufactured and sold by PM USA and Middleton, respectively, and (ii) oral tobacco products, including MST and snus products manufactured and sold by USSTC, and oral nicotine pouches sold by Helix. On October 1, 2021, UST LLC sold its Ste. Michelle Wine Estates Ltd. (Ste. Michelle) business. Prior to October 1, 2021, wine produced and/or sold by Ste. Michelle was a reportable segment. Results for innovative tobacco products and PMCC are included in “All Other.” Comparisons are to the corresponding prior-year period unless otherwise stated. Forward-Looking and Cautionary Statements This release contains projections of future results and other forward-looking statements that involve a number of risks and uncertainties and are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Important factors that may cause actual results and outcomes to differ materially from those contained in the projections and forward-looking statements included in this release are described in Altria’s publicly filed reports, including its Annual Report on Form 10-K for the year ended December 31, 2020 and its Quarterly Report on Form 10-Q for the period ended September 30, 2021. These factors include the following: Altria cautions that the foregoing list of important factors is not complete and does not undertake to update any forward-looking statements that it may make except as required by applicable law. All subsequent written and oral forward-looking statements attributable to Altria or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements referenced above. Schedule 1 ALTRIA GROUP, INC. and Subsidiaries Consolidated Statements of Earnings For the Quarters Ended December 31, (dollars in millions, except per share data) (Unaudited) 2021 2020 % Change Net revenues $ 6,255 $ 6,304 (0.8 ) % Cost of sales 1 1,771 1,909 Excise taxes on products 1 1,169 1,249 Gross profit 3,315 3,146 5.4 % Marketing, administration and research costs 473 474 Asset impairment and exit costs — (3 ) Operating companies income 2,842 2,675 6.2 % Amortization of intangibles 19 18 General corporate expenses 90 77 Corporate asset impairment and exit costs — (1 ) Operating income 2,733 2,581 5.9 % Interest and other debt expense, net 293 316 Net periodic benefit income, excluding service cost (50 ) (19 ) (Income) losses from equity investments 1 190 (195 ) (Gain) loss on Cronos-related financial instruments 20 (62 ) Earnings before income taxes 2,280 2,541 (10.3 ) % Provision for income taxes 656 619 Net earnings 1,624 1,922 (15.5 ) % Net losses attributable to noncontrolling interests — 2 Net earnings attributable to Altria $ 1,624 $ 1,924 (15.6 ) % Per share data: Diluted earnings per share attributable to Altria $ 0.88 $ 1.03 (14.6 ) % Weighted-average diluted shares outstanding 1,832 1,859 (1.5 ) % 1 Cost of sales includes charges for resolution expenses related to state settlement agreements and FDA user fees. Supplemental information concerning those items, excise taxes on products sold and (income) losses from equity investments is shown in Schedule 5. Schedule 2 ALTRIA GROUP, INC. and Subsidiaries Selected Financial Data For the Quarters Ended December 31, (dollars in millions) (Unaudited) Net Revenues Smokeable Oral Wine All Total 2021 $ 5,591 $ 663 $ — $ 1 $ 6,255 2020 5,567 632 180 (75 ) 6,304 % Change 0.4 % 4.9 % (100.0 ) % 100%+ (0.8 ) % Reconciliation: For the quarter ended December 31, 2020 $ 5,567 $ 632 $ 180 $ (75 ) $ 6,304 Operations 24 31 (180 ) 76 (49 ) For the quarter ended December 31, 2021 $ 5,591 $ 663 $ — $ 1 $ 6,255 Operating Companies Income (Loss) Smokeable Oral Wine All Other Total 2021 $ 2,493 $ 390 $ — $ (41 ) $ 2,842 2020 2,376 421 (13 ) (109 ) 2,675 % Change 4.9 % (7.4 ) % 100.0 % 62.4 % 6.2 % Reconciliation: For the quarter ended December 31, 2020 $ 2,376 $ 421 $ (13 ) $ (109 ) $ 2,675 NPM Adjustment Items - 2020 4 — — — 4 Asset impairment, exit, implementation, acquisition and disposition-related costs - 2020 2 (9 ) 16 — 9 Tobacco and health and certain other litigation items - 2020 6 — — — 6 12 (9 ) 16 — 19 Tobacco and health and certain other litigation items - 2021 (11 ) — — — (11 ) (11 ) — — — (11 ) Operations 116 (22 ) (3 ) 68 159 For the quarter ended December 31, 2021 $ 2,493 $ 390 $ — $ (41 ) $ 2,842 Schedule 3 ALTRIA GROUP, INC. and Subsidiaries Consolidated Statements of Earnings For the Years Ended December 31, (dollars in millions, except per share data) (Unaudited) 2021 2020 % Change Net revenues $ 26,013 $ 26,153 (0.5 ) % Cost of sales 1 7,119 7,818 Excise taxes on products 1 4,902 5,312 Gross profit 13,992 13,023 7.4 % Marketing, administration and research costs 2,015 1,855 Asset impairment and exit costs — (3 ) Operating companies income 11,977 11,171 7.2 % Amortization of intangibles 72 72 General corporate expenses 345 227 Corporate asset impairment and exit costs — (1 ) Operating income 11,560 10,873 6.3 % Interest and other debt expense, net 1,162 1,209 Loss on early extinguishment of debt 649 — Net periodic benefit income, excluding service cost (202 ) (77 ) Losses from equity investments 1 5,979 111 Impairment of JUUL equity securities — 2,600 Loss on Cronos-related financial instruments 148 140 Earnings before income taxes 3,824 6,890 (44.5 ) % Provision for income taxes 1,349 2,436 Net earnings 2,475 4,454 (44.4 ) % Net losses attributable to noncontrolling interests — 13 Net earnings attributable to Altria $ 2,475 $ 4,467 (44.6 ) % Per share data2: Diluted earnings per share attributable to Altria $ 1.34 $ 2.40 (44.2 ) % Weighted-average diluted shares outstanding 1,845 1,859 (0.8 ) % 1 Cost of sales includes charges for resolution expenses related to state settlement agreements and FDA user fees. Supplemental information concerning those items, excise taxes on products sold and income (losses) from equity investments is shown in Schedule 5. 2 Diluted earnings per share attributable to Altria are computed independently for each period. Accordingly, the sum of the quarterly earnings per share amounts may not agree to the year-to-date amounts. Schedule 4 ALTRIA GROUP, INC. and Subsidiaries Selected Financial Data For the Years Ended December 31, (dollars in millions) (Unaudited) Net Revenues Smokeable Oral Wine All Other Total 2021 $ 22,866 $ 2,608 $ 494 $ 45 $ 26,013 2020 23,089 2,533 614 (83 ) 26,153 % Change (1.0 ) % 3.0 % (19.5 ) % 100.0%+ (0.5 ) % Reconciliation: For the year ended December 31, 2020 $ 23,089 $ 2,533 $ 614 $ (83 ) $ 26,153 Operations (223 ) 75 (120 ) 128 (140 ) For the year ended December 31, 2021 $ 22,866 $ 2,608 $ 494 $ 45 $ 26,013 Operating Companies Income (Loss) Smokeable Oral Wine All Other Total 2021 $ 10,394 $ 1,659 $ 21 $ (97 ) $ 11,977 2020 9,985 1,718 (360 ) (172 ) 11,171 % Change 4.1 % (3.4 ) % 100.0%+ 43.6 % 7.2 % Reconciliation: For the year ended December 31, 2020 $ 9,985 $ 1,718 $ (360 ) $ (172 ) $ 11,171 NPM Adjustment Items - 2020 4 — — — 4 Asset impairment, exit, implementation, acquisition and disposition-related costs - 2020 2 (3 ) 411 — 410 Tobacco and health and certain other litigation items - 2020 79 — — — 79 COVID-19 special items - 2020 41 9 — — 50 126 6 411 — 543 NPM Adjustment Items - 2021 53 — — — 53 Asset impairment, exit, implementation, acquisition and disposition-related costs - 2021 — (37 ) (52 ) — (89 ) Tobacco and health and certain other litigation items - 2021 (83 ) — — — (83 ) (30 ) (37 ) (52 ) — (119 ) Operations 313 (28 ) 22 75 382 For the year ended December 31, 2021 $ 10,394 $ 1,659 $ 21 $ (97 ) $ 11,977 Schedule 5 ALTRIA GROUP, INC. and Subsidiaries Supplemental Financial Data (dollars in millions) (Unaudited) For the Quarters For the Years 2021 2020 2021 2020 The segment detail of excise taxes on products sold is as follows: Smokeable products $ 1,134 $ 1,212 $ 4,754 $ 5,162 Oral tobacco products 34 32 132 130 Wine — 5 14 19 All other 1 — 2 1 $ 1,169 $ 1,249 $ 4,902 $ 5,312 The segment detail of charges for resolution expenses related to state settlement agreements included in cost of sales is as follows: Smokeable products $ 1,086 $ 1,103 $ 4,269 $ 4,432 Oral tobacco products 2 2 9 9 All other 1 1 2 1 $ 1,089 $ 1,106 $ 4,280 $ 4,442 The segment detail of FDA user fees included in cost of sales is as follows: Smokeable products $ 67 $ 69 $ 273 $ 279 Oral tobacco products 2 1 5 5 $ 69 $ 70 $ 278 $ 284 The detail of (income) losses from equity investments is as follows: ABI $ (80 ) $ (83 ) $ 5,564 $ 223 Cronos 270 (12 ) 415 (12 ) JUUL — (100 ) — (100 ) $ 190 $ (195 ) $ 5,979 $ 111 Schedule 6 ALTRIA GROUP, INC. and Subsidiaries Net Earnings and Diluted Earnings Per Share - Attributable to Altria Group, Inc. For the Quarters Ended December 31, (dollars in millions, except per share data) (Unaudited) Net Earnings Diluted EPS 2021 Net Earnings $ 1,624 $ 0.88 2020 Net Earnings $ 1,924 $ 1.03 % Change (15.6 ) % (14.6 ) % Reconciliation: 2020 Net Earnings $ 1,924 $ 1.03 2020 NPM Adjustment Items 3 — 2020 Asset impairment, exit, implementation, acquisition and disposition-related costs 28 0.02 2020 Tobacco and health and certain other litigation items 5 — 2020 JUUL changes in fair value (100 ) (0.05 ) 2020 ABI-related special items 59 0.03 2020 Cronos-related special items (90 ) (0.04 ) 2020 Tax items 12 — Subtotal 2020 special items (83 ) (0.04 ) 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs (4 ) — 2021 Tobacco and health and certain other litigation items (25 ) (0.02 ) 2021 ABI-related special items (73 ) (0.04 ) 2021 Cronos-related special items (265 ) (0.15 ) 2021 Tax items (2 ) — Subtotal 2021 special items (369 ) (0.21 ) Fewer shares outstanding — 0.02 Change in tax rate (15 ) (0.01 ) Operations 167 0.09 2021 Net Earnings $ 1,624 $ 0.88 Schedule 7 ALTRIA GROUP, INC. and Subsidiaries Reconciliation of GAAP and non-GAAP Measures For the Quarters Ended December 31, (dollars in millions, except per share data) (Unaudited) Earnings Provision Net Net Earnings Diluted 2021 Reported $ 2,280 $ 656 $ 1,624 $ 1,624 $ 0.88 Asset impairment, exit, implementation, acquisition and disposition-related costs 3 (1 ) 4 4 — Tobacco and health and certain other litigation items 34 9 25 25 0.02 ABI-related special items 92 19 73 73 0.04 Cronos-related special items 266 1 265 265 0.15 Tax items — (2 ) 2 2 — 2021 Adjusted for Special Items $ 2,675 $ 682 $ 1,993 $ 1,993 $ 1.09 2020 Reported $ 2,541 $ 619 $ 1,922 $ 1,924 $ 1.03 NPM Adjustment Items 4 1 3 3 — Asset impairment, exit, implementation, acquisition and disposition-related costs 16 (12 ) 28 28 0.02 Tobacco and health and certain other litigation items 7 2 5 5 — JUUL changes in fair value (100 ) — (100 ) (100 ) (0.05 ) ABI-related special items 74 15 59 59 0.03 Cronos-related special items (93 ) (3 ) (90 ) (90 ) (0.04 ) Tax items — (12 ) 12 12 — 2020 Adjusted for Special Items $ 2,449 $ 610 $ 1,839 $ 1,841 $ 0.99 2021 Reported Net Earnings $ 1,624 $ 0.88 2020 Reported Net Earnings $ 1,924 $ 1.03 % Change (15.6 ) % (14.6 ) % 2021 Net Earnings Adjusted for Special Items $ 1,993 $ 1.09 2020 Net Earnings Adjusted for Special Items $ 1,841 $ 0.99 % Change 8.3 % 10.1 % Schedule 8 ALTRIA GROUP, INC. and Subsidiaries Net Earnings and Diluted Earnings Per Share - Attributable to Altria Group, Inc. For the Years Ended December 31, (dollars in millions, except per share data) (Unaudited) Net Earnings Diluted EPS1 2021 Net Earnings $ 2,475 $ 1.34 2020 Net Earnings $ 4,467 $ 2.40 % Change (44.6 ) % (44.2 ) % Reconciliation: 2020 Net Earnings $ 4,467 $ 2.40 2020 NPM Adjustment Items 3 — 2020 Asset impairment, exit, implementation, acquisition and disposition-related costs 342 0.18 2020 Tobacco and health and certain other litigation items 62 0.03 2020 Impairment of JUUL equity securities 2,600 1.40 2020 JUUL changes in fair value (100 ) (0.05 ) 2020 ABI-related special items 603 0.32 2020 Cronos-related special items 53 0.03 2020 COVID-19 special items 37 0.02 2020 Tax items 50 0.03 Subtotal 2020 special items 3,650 1.96 2021 NPM Adjustment Items 57 0.03 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs (99 ) (0.05 ) 2021 Tobacco and health and certain other litigation items (138 ) (0.07 ) 2021 ABI-related special items (4,901 ) (2.66 ) 2021 Cronos-related special items (470 ) (0.25 ) 2021 Loss on early extinguishment of debt (496 ) (0.27 ) 2021 Tax items 3 — Subtotal 2021 special items (6,044 ) (3.27 ) Fewer shares outstanding — 0.03 Change in tax rate (33 ) (0.02 ) Operations 435 0.24 2021 Net Earnings $ 2,475 $ 1.34 1 Diluted earnings per share attributable to Altria are computed independently for each period. Accordingly, the sum of the quarterly earnings per share amounts may not agree to the year-to-date amounts. Schedule 9 ALTRIA GROUP, INC. and Subsidiaries Reconciliation of GAAP and non-GAAP Measures For the Years Ended December 31, (dollars in millions, except per share data) (Unaudited) Earnings Provision Net Net Earnings Diluted 2021 Reported $ 3,824 $ 1,349 $ 2,475 $ 2,475 $ 1.34 NPM Adjustment Items (76 ) (19 ) (57 ) (57 ) (0.03 ) Asset impairment, exit, implementation, acquisition and disposition-related costs 120 21 99 99 0.05 Tobacco and health and certain other litigation items 182 44 138 138 0.07 ABI-related special items 6,203 1,302 4,901 4,901 2.66 Cronos-related special items 466 (4 ) 470 470 0.25 Loss on early extinguishment of debt 649 153 496 496 0.27 Tax items — 3 (3 ) (3 ) — 2021 Adjusted for Special Items $ 11,368 $ 2,849 $ 8,519 $ 8,519 $ 4.61 2020 Reported $ 6,890 $ 2,436 $ 4,454 $ 4,467 $ 2.40 NPM Adjustment Items 4 1 3 3 — Asset impairment, exit, implementation, acquisition and disposition-related costs 431 89 342 342 0.18 Tobacco and health and certain other litigation items 83 21 62 62 0.03 Impairment of JUUL equity securities 2,600 — 2,600 2,600 1.40 JUUL changes in fair value (100 ) — (100 ) (100 ) (0.05 ) ABI-related special items 763 160 603 603 0.32 Cronos-related special items 51 (2 ) 53 53 0.03 COVID-19 special items 50 13 37 37 0.02 Tax items — (50 ) 50 50 0.03 2020 Adjusted for Special Items $ 10,772 $ 2,668 $ 8,104 $ 8,117 $ 4.36 2021 Reported Net Earnings $ 2,475 $ 1.34 2020 Reported Net Earnings $ 4,467 $ 2.40 % Change (44.6 ) % (44.2 ) % 2021 Net Earnings Adjusted for Special Items $ 8,519 $ 4.61 2020 Net Earnings Adjusted for Special Items $ 8,117 $ 4.36 % Change 5.0 % 5.7 % 1 Diluted earnings per share attributable to Altria are computed independently for each period. Accordingly, the sum of the quarterly earnings per share amounts may not agree to the year-to-date amounts. Schedule 10 ALTRIA GROUP, INC. and Subsidiaries Condensed Consolidated Balance Sheets (dollars in millions) (Unaudited) December 31, 2021 December 31, 2020 Assets Cash and cash equivalents $ 4,544 $ 4,945 Inventories 1,194 1,966 Other current assets 345 206 Property, plant and equipment, net 1,553 2,012 Goodwill and other intangible assets, net 17,483 17,792 Investments in equity securities 13,481 19,529 Other long-term assets 923 964 Total assets $ 39,523 $ 47,414 Liabilities and Stockholders’ Equity (Deficit) Current portion of long-term debt $ 1,105 $ 1,500 Accrued settlement charges 3,349 3,564 Other current liabilities 4,125 3,999 Long-term debt 26,939 27,971 Deferred income taxes 3,692 4,532 Accrued pension costs 200 551 Accrued postretirement health care costs 1,436 1,951 Other long-term liabilities 283 381 Total liabilities 41,129 44,449 Redeemable noncontrolling interest — 40 Total stockholders’ equity (deficit) (1,606 ) 2,925 Total liabilities and stockholders’ equity (deficit) $ 39,523 $ 47,414 Total debt $ 28,044 $ 29,471 Schedule 11 ALTRIA GROUP, INC. and Subsidiaries Supplemental Financial Data for Special Items For the Quarters Ended December 31, (dollars in millions) (Unaudited) Cost of Marketing, administration and research costs Asset General corporate Corporate Interest and (Income) (Gain) loss on 2021 Special Items - (Income) Expense Asset impairment, exit, implementation, acquisition and disposition-related costs $ — $ — $ — $ 3 $ — $ — $ — $ — Tobacco and health and certain other litigation items — 11 — 20 — 3 — — ABI-related special items — — — — — — 92 — Cronos-related special items — — — — — — 246 20 2020 Special Items - (Income) Expense NPM Adjustment Items $ 4 $ — $ — $ — $ — $ — $ — $ — Asset impairment, exit, implementation, acquisition and disposition-related costs 16 (4 ) (3 ) 8 (1 ) — — — Tobacco and health and certain other litigation items — 6 — — — 1 — — JUUL changes in fair value — — — — — — (100 ) — ABI-related special items — — — — — — 74 — Cronos-related special items — — — — — — (31 ) (62 ) Note: This schedule is intended to provide supplemental financial data for certain income and expense items that management believes are not part of underlying operations and their presentation in Altria’s consolidated statements of earnings. This schedule is not intended to provide, or reconcile, non-GAAP financial measures. Schedule 12 ALTRIA GROUP, INC. and Subsidiaries Supplemental Financial Data for Special Items For the Years Ended December 31, (dollars in millions) (Unaudited) Cost of Marketing, administration Asset General Corporate Interest Loss on early (Income) Impairment (Gain) loss 2021 Special Items - (Income) Expense NPM Adjustment Items $ (53 ) $ — $ — $ — $ — $ (23 ) $ — $ — $ — $ — Asset impairment, exit, implementation, acquisition and disposition-related costs 1 88 — 31 — — — — — — Tobacco and health and certain other litigation items — 83 — 90 — 9 — — — — ABI-related special items — — — — — — — 6,203 — — Cronos-related special items — — — — — — — 318 — 148 Loss on early extinguishment of debt — — — — — — 649 — — — 2020 Special Items - (Income) Expense NPM Adjustment Items $ 4 $ — $ — $ — $ — $ — $ — $ — $ — $ — Asset impairment, exit, implementation, acquisition and disposition-related costs 411 2 (3 ) 22 (1 ) — — — — — Tobacco and health and certain other litigation items — 79 — — — 4 — — — — Impairment of JUUL equity securities — — — — — — — — 2,600 — JUUL changes in fair value — — — — — — — (100 ) — — ABI-related special items — — — — — — — 763 — — Cronos-related special items — — — — — — — (89 ) — 140 COVID-19 special items 50 — — — — — — — — — Note: This schedule is intended to provide supplemental financial data for certain income and expense items that management believes are not part of underlying operations and their presentation in Altria’s consolidated statements of earnings. This schedule is not intended to provide, or reconcile, non-GAAP financial measures. View source version on businesswire.com: https://www.businesswire.com/news/home/20220126005529/en/ Altria Client Services Altria Client Services Source: Altria Group, Inc. Altria Reports 2021 Fourth-Quarter and Full-Year Results; Provides 2022 Full-Year Earnings Guidance
point change
point change
Products
Tobacco
Products
Other
Products
Tobacco
Products
Products
Tobacco
Products
Products
Tobacco
Products
Ended December 31,
Ended December 31,
before
Income Taxes
for Income
Taxes
Earnings
Attributable to
Altria
EPS
before
Income
Taxes
for Income
Taxes
Earnings
Attributable to
Altria
EPS1
Sales
impairment
and
exit costs
expenses
asset
impairment
and exit costs
other debt
expense, net
losses from
equity
investments
Cronos-related
financial
instruments
Sales
and research
costs
impairment
and exit
costs
corporate
expenses
asset
impairment
and exit
costs
and other
debt
expense,
net
extinguishment
of debt
losses from
equity
investments
of JUUL
equity
securities
on Cronos-related
financial instruments
Investor Relations
804-484-8222
Media Relations
804-484-8897
Press Releases – Altria (2024)
References
- https://investor.altria.com/press-releases/default.aspx
- https://investor.altria.com/press-releases/news-details/2024/Altria-Reports-2023-Fourth-Quarter-and-Full-Year-Results-Provides-2024-Full-Year-Earnings-Guidance-Announces-New-1-Billion-Share-Repurchase-Program/default.aspx
- https://investor.altria.com/press-releases/news-details/2022/Altria-Reports-2021-Fourth-Quarter-and-Full-Year-Results-Provides-2022-Full-Year-Earnings-Guidance/default.aspx
- https://investor.altria.com/stock-performance/dividend-information/default.aspx
Top Articles
Walmart Map – Walmart Locator
Refill your prepaid account
Neo-Tsymburskian Cycles in the History of Russian-Western Relations
The 7 Best Locations on the Shoreline Map in Escape from Tarkov
Watchseries To New Domain
Start Your Vegas-X App Download Now: Enjoy Gaming
Chevrolet Silverado 5500 Dump Trucks for Sale near Kent, WA | Comvoy
Chevrolet Silverado 4500 Dump Trucks for Sale near Richardson, TX | Comvoy
Subaru Sambar For Sale Craigslist
Seekers Notes Facebook
L’ Elegance – Sold Listings and Market Reports
The Knapsack Problem
Latest Posts
Here’s How to Use Walmart Receipt Lookup If You Lost Your Receipt
Grocery Store Near Me - Grocery Delivery Or Pickup - Redmond, WA
Article information
Author: Dean Jakubowski Ret
Last Updated:
Views: 6322
Rating: 5 / 5 (50 voted)
Reviews: 89% of readers found this page helpful
Author information
Name: Dean Jakubowski Ret
Birthday: 1996-05-10
Address: Apt. 425 4346 Santiago Islands, Shariside, AK 38830-1874
Phone: +96313309894162
Job: Legacy Sales Designer
Hobby: Baseball, Wood carving, Candle making, Jigsaw puzzles, Lacemaking, Parkour, Drawing
Introduction: My name is Dean Jakubowski Ret, I am a enthusiastic, friendly, homely, handsome, zealous, brainy, elegant person who loves writing and wants to share my knowledge and understanding with you.